Tulane University researchers have developed a new drug that is effective against non-severe cases of malaria, according to results from an FDA-supervised clinical trial published online in The Lancet Infectious Diseases.
The results are significant as public health experts have long warned that the parasite responsible for most malaria cases, Plasmodium falciparum, is developing resistance to widely used treatments. New medications are needed to build up secondary defenses against drug-resistant strains of the parasite.
The drug, called AQ-13, was able to clear the parasite responsible for the disease within a week, matching the effectiveness of the most widely used treatment regimen.
“The potential long-term implications are bigger than one drug. The conceptual step here is that if you understand the resistance well enough, you may be actually be able to develop others as well.”
Dr. Donald Krogstad
“The clinical trial results are extraordinarily encouraging,” said Dr. Donald Krogstad, senior author and professor of tropical medicine at Tulane University School of Public Health and Tropical Medicine. “Compared to the current first-line recommendation for treatment of malaria, the new drug comes out very well.”
Mosquitoes infected by a parasite spread malaria, causing more than 200 million illnesses across the globe and more than 400,000 deaths annually. For decades, chloroquine was used to treat malaria until Plasmodium falciparum developed resistance. Now, a drug combination — artemether and lumefantrine — is the primary treatment for malaria although resistance is also developing to the drug combination in some countries.
Researchers recruited 66 adult men in Mali with uncomplicated malaria, which is defined as malaria that isn’t life threatening. Half were treated with AQ-13 and the other half received artemether and lumefantrine. Both drug groups had similar cure rates. However, five participants in AQ-13 group left the study or were lost to follow-up and two participants in the artemether/lumefantrine group had late treatment failures with recurrence of their original infections.
Researchers hope to expand testing of the drug to more participants, including women and children, before it can be widely recommended as a new treatment. Krogstad said that the same biotechnology that helped the team develop the new drug has also identified similar drugs that also hold promise against drug-resistant parasites.
Learn more: New Tulane University drug effective against malaria
The Latest on: Malaria
[google_news title=”” keyword=”malaria” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]- Mortein takes its fight against Malaria to Communities across Nigeriaon May 3, 2024 at 1:01 am
In a significant push in its Fight to End Malaria, Nigeria’s top insecticide brand, Mortein, recently carried out an impactful community educational campaign on malaria prevention in cities across ...
- Mortein takes fight against malaria to communities across Nigeriaon May 3, 2024 at 12:02 am
In a significant push in its Fight to End Malaria, Nigeria’s top insecticide brand, Mortein, recently carried out an impactful community educational campaign on malaria prevention in cities across ...
- Deeper understanding of malaria parasite development unlocks opportunities to block disease spreadon May 2, 2024 at 3:21 pm
Natural malaria infections have been genetically analysed at a higher resolution than ever before, giving insights that could help understand and block transmission.
- Malaria may shorten leukocyte telomeres among sub-Saharan Africanson May 2, 2024 at 1:24 pm
The length of telomeres in white blood cells, known as leukocytes, varies significantly among sub-Saharan African populations, researchers report. Moreover, leukocyte telomere length (LTL) is ...
- Malaria Parasite Alters Gene Usage to Prepare for Transmissionon May 2, 2024 at 11:01 am
For the first time the developmental stages of the deadliest human malaria parasite, Plasmodium falciparum, have been mapped in high resolution, allowing scientists to better understand this ...
- Deeper understanding of malaria parasite sexual development unlocks opportunities to block disease spreadon May 2, 2024 at 11:00 am
For the first time, the developmental stages of the deadliest human malaria parasite have been mapped in high resolution, allowing researchers to understand this ever-adapting adversary in more detail ...
- Blood diagnostics device modeled on leeches could be use to detect malariaon May 2, 2024 at 9:22 am
Researchers at ETH Zurich have developed a safe and inexpensive device for reliable blood measurements. It works using a suction cup and could also be employed to diagnose the tropical disease malaria ...
- Malaria may shorten leukocyte telomeres among sub-Saharan Africans, study findson May 2, 2024 at 8:01 am
The length of telomeres in white blood cells, known as leukocytes, varies significantly among sub-Saharan African populations, researchers report in The American Journal of Human Genetics. Moreover, ...
- New monoclonal antibody vaccine slashes malaria risk in childrenon April 30, 2024 at 8:19 pm
A recent study demonstrates that the monoclonal antibody-based vaccine L9LS is safe for children aged 6 to 10 and significantly reduces the risk of malaria infection and clinical symptoms by 70% and ...
- Malaria: The plight of residents of low-income neighbourhoodson April 30, 2024 at 2:25 am
Ponds of dirty water on the streets of Makoko, an informal neighborhood in Lagos, and a lack of decent living conditions provide ideal breeding conditions for malaria-spreading mosquitoes. Globally, ...
via Google News and Bing News